+ 1 888 391 5441

Global Heparin Market

Date:22-10-2013

Heparin is an anticoagulant which is used for preventing the formation of blood clots. Patients who suffer from certain medical conditions or are undergoing surgery have a greater likelihood of clot formation. Although heparin does not help in dissolving blood clots that have already formed, it may prevent blood clots from becoming larger. It is used in treating and preventing certain conditions of the heart, lungs and blood vessels. Moreover, heparin is also administered during blood transfusions, open-heart surgery, kidney dialysis, etc. to prevent blood clotting.

The global heparin market has been witnessing a steady rise in the last couple of years. The market is expected to grow at an annual rate of 12 percent from 2012 to 2018. Some of the reasons for this growth are rise in healthcare expenditure, global aging population and new research and development initiatives undertaken by the drug manufacturers. Growth in the heparin industry is also augmented by the demand of heparin in emerging economies, especially China. As the market for heparin is a niche market, it provides great growth opportunities to pharmaceutical companies manufacturing heparin.

As heparin is used for the treatment of deep-vein thrombosis and pulmonary embolism, the demand for the drug has gone up considerably. The global aging population is also boosting the demand of heparin drug. People become sedentary and inactive as they age. Inactivity decreases the rate of blood flow which increases the possibility of the formation of blood clots.

The global market for heparin can be divided according to the types of heparin available. One is regular heparin and the other is low molecular weight heparin. The market for low molecular weight heparin can be further subdivided into dalteparin, tinzaparin and enoxaparin. Low molecular weight heparin is used for the treatment of renal impairment, atrial fibrillation, pulmonary embolism and hemodialysis. Some of the largest manufacturers of heparin are GlaxoSmithKline PLC, Wanbang Biochemical Pharmaceutical Co. Ltd., Pfizer Inc., Bristol-Myers Squibb Co. and Leo Pharma Inc.

Explore the latest market research report on heparin @ http://www.chinamarketresearchreports.com/114641.html.

Why http://www.chinamarketresearchreports.com
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy